The bank for a changing world

For a third consecutive year, BNP Paribas Corporate & Investment Banking partners with the Institut Pasteur, to support medical research in some twenty countries

  • 25.02.2011

In line with the Group's philanthropy policy, which is led by the BNP Paribas Foundation, BNP Paribas Corporate & Investment Banking (CIB) has renewed its partnership with the Institut Pasteur offering financial support to help medical research across twenty countries. The research teams supported come from the International Network of the Institut Pasteur in addition to laboratories working in collaboration with the Institut in Paris. Donations over the past three years total 1.3 milllion euros.

The chosen research programs focus on vaccines against measles and HIV (France), hepatitis C (Japan, Spain), malaria (Brazil), polio (Russia), tuberculosis (The Netherlands), dengue fever (Hong-Kong) amongst others.

“We share the international scope and the values of excellence, innovation and quality that are embedded in the projects supported by the Institut Pasteur around the world,” said Alain Papiasse, Head of BNP Paribas Corporate & Investment Banking. “That is why we are proud to support such projects and contribute to advances in medical research. As a major international company, we consider this commitment to be an integral part of our responsibility to society.”

Pr Alice Dautry, Director General of the Pasteur Institute, added: “For 120 years sponsorship has played a major role in the Institut's development. The loyal support given by BNP Paribas and its Foundation to our researchers is part of this tradition. It also bears witness to the excellent relationship developed between our two organizations over the years and to the importance that BNP Paribas places on public health issues.”

About BNP Paribas CIB
BNP Paribas Corporate and Investment Banking (CIB) (http// has almost 20,000 employees deployed in over 50 countries around the world and serves 13,000 corporate and institutional clients. BNP Paribas excels in three fundamental sectors in particular:
Derivatives – it is one of the leading global players in rates, credit, forex, commodity and equity derivatives.
Capital markets – it is amongst the top European institutions for both equity and debt activities (bond and equity issues, securitization, convertibles).
Structured finance – it is amongst the world leaders for export, asset, project and commodity finance.

About Institut Pasteur
Louis Pasteur created the Institut Pasteur in 1887 as a private non-profit foundation that rapidly became world-renowned for its biomedical research. The main aim of the Institut Pasteur is understanding and preventing diseases throughout the world through excellent scientific and public health research, teaching and other activities.
Together with its major contribution to a deeper understanding of fundamental aspects of life, the Institut Pasteur continues to devote a large part of its efforts to infectious diseases, inherited disorders, neurodegenerative diseases and certain cancers. Close to 2,600 people work on its main campus in Paris, which is at the heart of an international network of 32 research institutes on 5 continents. Over the years, 10 Institut Pasteur researchers have received the Nobel Prize.
Press contact(s)
Press contact:
Pascal Hénisse - +33 1 40 14 65 14 – pascal.henisse [at] bnpparibas (dot) com